Premium Phosphosite-Specific 7TM Antibodies
Novel Tools for Your GPCR Research
Select Your Country of Delivery below

Somatostatin Receptor 5 Antibodies

Close filters
No results were found for the filter!
Citations
KO-Validated
Immunohistochemical identification of Somatostatin Receptor 5 in human pancreatic islets
SST5 (IHC-grade), Somatostatin Receptor 5 Antibody
The SST5 receptor antibody is directed against the distal end of the carboxyl-terminal tail of human Somatostatin Receptor 5. In can be used to detect total SST5 receptors in Western blots independent of phosphorylation. The SST5...
$ 400.00 *
Details
Citations
KO-Validated
Validation of the Somatostatin Receptor 5 in transfected HEK293 cells.
SST5 (non-phospho), Somatostatin Receptor 5...
The non-phospho-SST5 receptor antibody is directed against the distal end of the carboxyl-terminal tail of human SST5. In can be used to detect total SST5 receptors in Western blots independent of phosphorylation. The non-phospho-SST5...
$ 400.00 *
Details
Citations
Agonist-induced Threonine333 phosphorylation of the Somatostatin Receptor 5.
pT333-SST5 (phospho-Somatostatin Receptor 5...
Threonine333 (T333) is a major phosphorylation site of the human somatostatin receptor 5 (SST5). The pT333-SST5 antibody detects phosphorylation in response to high-efficacy agonists such as pasireotide but not after activation of PKC....
$ 400.00 *
Details

SST5

The somatostatin receptor 5 (SST5) is highly expressed in the anterior pituitary and other endocrine cells, where it inhibits hormone secretion. It is the primary target for pasireotide (Signifor) which is the first line medical treatment for adrenocorticotropic hormone (ACTH)-producing adenomas (Cushing’s disease). SST5 desensitization and internalization are regulated by phosphorylation of carboxyl-terminal threonine333 (pT333-SST5). Threonine347 is constitutively phosphorylated in the absence of agonist. This nomenclature refers to the human SST5. Agonist-induced phosphorylation of T333 is mediated by GRK2. SST5 dephosphorylation is primarily mediated by protein phosphatase 1 gamma (PP1γ). For more information on SST5 pharmacology please refer to the IUPHAR database. For further reading refer to:

Petrich A, Mann A, Kliewer A, Nagel F, Strigli A, Märtens JC, Pöll F, Schulz S. Phosphorylation of threonine 333 regulates trafficking of the human sst5 somatostatin receptor. Mol Endocrinol. 2013 Apr;27(4):671-82. doi: 10.1210/me.2012-1329. Epub 2013 Feb 15. PubMed PMID: 23418396; PubMed Central PMCID: PMC5416807.

Lehmann A, Kliewer A, Märtens JC, Nagel F, Schulz S. Carboxyl-terminal receptor domains control the differential dephosphorylation of somatostatin receptors by protein phosphatase 1 isoforms. PLoS One. 2014 Mar 17;9(3):e91526. doi: 10.1371/journal.pone.0091526. eCollection 2014. PubMed PMID: 24637622; PubMed Central PMCID: PMC3956607.

Kliewer A, Mann A, Petrich A, Pöll F, Schulz S. A transplantable phosphorylation probe for direct assessment of G protein-coupled receptor activation. PLoS One. 2012;7(6):e39458. doi: 10.1371/journal.pone.0039458. Epub 2012 Jun 26. PubMed PMID: 22745760; PubMed Central PMCID: PMC3383726.

The somatostatin receptor 5 (SST5) is highly expressed in the anterior pituitary and other endocrine cells, where it inhibits hormone secretion. It is the primary target for pasireotide... read more »
Close window
Somatostatin Receptor 5 Antibodies

SST5

The somatostatin receptor 5 (SST5) is highly expressed in the anterior pituitary and other endocrine cells, where it inhibits hormone secretion. It is the primary target for pasireotide (Signifor) which is the first line medical treatment for adrenocorticotropic hormone (ACTH)-producing adenomas (Cushing’s disease). SST5 desensitization and internalization are regulated by phosphorylation of carboxyl-terminal threonine333 (pT333-SST5). Threonine347 is constitutively phosphorylated in the absence of agonist. This nomenclature refers to the human SST5. Agonist-induced phosphorylation of T333 is mediated by GRK2. SST5 dephosphorylation is primarily mediated by protein phosphatase 1 gamma (PP1γ). For more information on SST5 pharmacology please refer to the IUPHAR database. For further reading refer to:

Petrich A, Mann A, Kliewer A, Nagel F, Strigli A, Märtens JC, Pöll F, Schulz S. Phosphorylation of threonine 333 regulates trafficking of the human sst5 somatostatin receptor. Mol Endocrinol. 2013 Apr;27(4):671-82. doi: 10.1210/me.2012-1329. Epub 2013 Feb 15. PubMed PMID: 23418396; PubMed Central PMCID: PMC5416807.

Lehmann A, Kliewer A, Märtens JC, Nagel F, Schulz S. Carboxyl-terminal receptor domains control the differential dephosphorylation of somatostatin receptors by protein phosphatase 1 isoforms. PLoS One. 2014 Mar 17;9(3):e91526. doi: 10.1371/journal.pone.0091526. eCollection 2014. PubMed PMID: 24637622; PubMed Central PMCID: PMC3956607.

Kliewer A, Mann A, Petrich A, Pöll F, Schulz S. A transplantable phosphorylation probe for direct assessment of G protein-coupled receptor activation. PLoS One. 2012;7(6):e39458. doi: 10.1371/journal.pone.0039458. Epub 2012 Jun 26. PubMed PMID: 22745760; PubMed Central PMCID: PMC3383726.

Recently viewed